You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,011,857


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,011,857
Title:Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
Abstract: The invention provides mannosidases capable of uncapping mannose-1-phospho-6-mannose moieties and demannosylating phosphorylated N-glycans, methods of using such mannosidases, glycoproteins produced using the methods, as well as methods of facilitating mammalian cellular uptake of glycoproteins.
Inventor(s): Piens; Kathleen Camilla Telesphore Alida Maria (Ghent, BE), Vervecken; Wouter (Landskouter, BE), Valevska; Albena Vergilieva (Astene, BE), Pynaert; Gwenda Noella (Aalter, BE)
Assignee: Oxyrane UK Limited (Manchester, GB)
Application Number:15/087,201
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding and Analyzing U.S. Patent Claims: A Comprehensive Guide

Introduction

Patent claims are the heart of any patent application, defining the scope of protection for an invention. For U.S. Patent 10,011,857, or any other patent, understanding these claims is crucial for inventors, patent attorneys, and businesses. This article will delve into the components of a U.S. patent, the significance of claims, and how to analyze them within the broader patent landscape.

Components of a U.S. Patent

A U.S. patent is a complex document with several key sections:

Document Number and Type

  • The document number, prefixed with "US," indicates it is a U.S. patent. The "B2" code signifies that the patent has a previously published application[1].

Application and Patent Dates

  • The application number, date of application, and date of patent issuance are critical for understanding the timeline of the patent process[1].

Classification

  • The International Patent Classification (IPC) and national classification codes help categorize the invention, making it easier to search and compare with prior art[1].

Title and Abstract

  • The title provides a brief description of the invention, while the abstract offers a non-technical summary of the invention's essence[1].

Field of Search and References

  • The field of search indicates the classifications consulted during the prior art search, and references cite related prior art documents and publications[1].

Inventors, Applicants, and Assignees

  • These sections identify the individuals or organizations involved in the invention, application, and ownership of the patent[1].

The Specification

The specification is a detailed written description of the invention, including:

Description of the Drawings

  • Drawings are included to illustrate the technical details of the invention, though not required for process or method inventions[1].

Prior Art Discussion

  • A discussion of related prior art helps contextualize the invention and its innovations[1].

Technical Problem and Solution

  • The specification explains the specific technical problem the invention solves and how it does so[1].

Preferred Embodiment

  • This section describes the best way to practice the invention as conceived by the inventors[1].

Claims

Claims are the most critical part of a patent, defining the legal boundaries of the invention.

Structure of Claims

  • Claims are typically preceded by "I claim" or "What is claimed" and are numbered. They must be clear and concise, defining the scope of protection[1].

Types of Claims

  • Independent claims stand alone and define the invention broadly, while dependent claims refer back to independent claims and add additional limitations[1].

Example of a Claim

  • For instance, a claim might describe a portable electronic device with specific components and their functions, such as an antenna and frequency shields[1].

Analyzing Patent Claims

Understanding the Scope of Protection

  • Claims define what is protected by the patent. Analyzing these claims helps in understanding the legal boundaries of the invention[1].

Anticipation and Novelty

  • A claim can be rejected if it is anticipated by prior art, meaning every element of the claim must be found in a single prior art reference[4].

Subject Matter Eligibility

  • Claims must also meet the subject matter eligibility criteria under 35 U.S.C. § 101, ensuring the invention is not an abstract idea, natural phenomenon, or something otherwise ineligible for patent protection[5].

The Importance of Proper Inventorship

Determining the true inventors is crucial for the validity of the patent.

Conception and Reduction to Practice

  • Inventorship is determined by who conceived the idea of the invention, not who reduced it to practice. Conception is complete when the idea is definite and permanent enough for someone with ordinary skill to reduce it to practice[3].

Correcting Errors in Inventorship

  • Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable. It is essential to accurately determine inventorship before filing the patent application[3].

Patent Landscape and Competitive Analysis

Increasing Complexity

  • The number of patent applications and claims is increasing, making it challenging to navigate the patent landscape. Technology innovations and legal precedents contribute to this complexity[2].

Automated Tools for Analysis

  • Tools like the Patent Claims Analysis System can help in managing and analyzing large numbers of claims, making it easier to understand the competitive position of a patent[2].

Case Studies and Examples

Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd.

  • This case highlights the importance of claim amendments during prosecution and how they can limit the scope of protection through prosecution history estoppel[2].

Frank’s Casing Crew v. PMR Technologies

  • This case illustrates the consequences of deceptive intent in naming inventors, leading to an unenforceable patent[3].

Key Takeaways

  • Claims Define the Invention: Claims are the core of a patent, defining what is protected and distinguishing the invention from prior art.
  • Proper Inventorship: Accurate determination of inventorship is vital for the validity and enforceability of the patent.
  • Subject Matter Eligibility: Claims must meet the criteria under 35 U.S.C. § 101 to ensure the invention is eligible for patent protection.
  • Anticipation and Novelty: Claims must be novel and non-obvious over prior art to be granted.
  • Automated Analysis Tools: These tools can help in managing and analyzing complex patent claims and landscapes.

FAQs

What is the purpose of the claims section in a U.S. patent?

The claims section defines the legal boundaries of the invention, specifying what is protected by the patent.

How are inventors determined for a U.S. patent application?

Inventors are determined by who conceived the idea of the invention, not who reduced it to practice. Conception must be definite and permanent enough for someone with ordinary skill to reduce it to practice.

What happens if a claim is anticipated by prior art?

If a claim is anticipated by prior art, it can be rejected under 35 U.S.C. § 102, meaning every element of the claim must be found in a single prior art reference.

Why is subject matter eligibility important for patent claims?

Subject matter eligibility ensures that the invention is not an abstract idea, natural phenomenon, or something otherwise ineligible for patent protection under 35 U.S.C. § 101.

Can errors in inventorship be corrected after a patent is issued?

Errors in inventorship can be corrected, but if there is deceptive intent, the patent can be rendered unenforceable. Corrections are easier to make while the patent application is pending.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Patents.google.com: US20110138338A1 - Patent Claims Analysis System and Method.
  3. Agsi.oregonstate.edu: Determining Inventorship for US Patent Applications.
  4. USPTO.gov: 2131-Anticipation — Application of 35 U.S.C. 102.
  5. Bitlaw.com: Patent Law in the United States.

More… ↓

⤷  Subscribe

Details for Patent 10,011,857

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 May 05, 2004 ⤷  Subscribe 2030-09-29
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 December 02, 2004 ⤷  Subscribe 2030-09-29
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 October 26, 2004 ⤷  Subscribe 2030-09-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.